Key Takeaways from Medtrade 2024

Insights for the HME Community

Medtrade 2024 saw a significant increase in attendance, drawing participants from every state except Rhode Island and from 35 countries, according to officials from Medtrade. This reaffirms Medtrade's status as the leading event for home medical equipment (HME) professionals in the United States. The conference featured a packed agenda with insightful sessions, panel discussions, and numerous networking opportunities. It provided attendees with valuable knowledge and strategic guidance. The key takeaways from this year’s conference are expected to have a major impact on the future of the HME industry.

1. The Crucial Role of the HME Community

The Medtrade 2024 conference showcased the HME community's commitment to facing industry challenges together. By gathering professionals nationwide, it emphasized the importance of collaboration in overcoming obstacles and sharing innovative solutions. The conference focused on key areas like adapting to stricter payer policies, improving operational efficiency, and navigating audits. It highlighted strategies for document retention, EMR implementation, understanding Continuous Glucose Monitors (CGM), navigating Medicare Advantage, and coping with current audit climates and TPE trends. Additionally, it addressed supply chain disruptions, rising costs, and integrating AI in healthcare, all aimed at fostering innovation and compliance.

The collective enthusiasm for sharing success stories and lessons learned underscored a shared dedication to continuous improvement and innovation.

2. Navigating the Change Healthcare Outage

The recent Change Healthcare outage shed light on the healthcare supply chain's vulnerabilities, capturing widespread attention. The discussion extended beyond immediate effects, focusing on long-term strategies to mitigate such risks. It became evident that diversifying technology partners and strengthening contingency plans are essential for ensuring healthcare services' continuity and reliability. Prochant's proactive establishment of a "war room" to navigate the evolving challenges and the operationalization of alternative clearinghouses, such as Inovalon, Availity, and Waystar, demonstrated a decisive and adaptive response to maintaining essential operations amidst technological disruptions.

3. Embracing Automation and AI

The excitement at Medtrade centered on the potential of automation and artificial intelligence (AI) to redefine the HME sector. With the late 2023 launch of OpenAI's ChatGPT, AI emerged as a significant driver for the future, offering opportunities for automation to streamline repetitive tasks. Emphasizing AI's role in making data entry and processing more efficient presents an accessible opportunity for HME companies. Dedicated sessions illustrated how tech-enabled solutions, especially those automating routine tasks and leveraging AI for predictive analytics, can significantly boost operational efficiency, minimize errors, and enhance patient care. For instance, ResMed’s use of AI for patient adherence predictions exemplifies how HME companies can optimize focus on patients to maximize adherence and reimbursements.

4. Cash Flow

At Medtrade, cash flow was the burning issue, emphasizing the need for HME providers to implement effective strategies for improving financial health. Key actionable steps discussed included streamlining billing processes, aggressively managing and appealing denials, and ensuring prompt follow-up on overdue payments to keep the cash flowing. The aim is to create a robust system that not only handles current financial pressures but also sets the stage for sustainable growth.


This year’s Medtrade not only served as an invaluable platform for learning and networking but also spotlighted the HME industry's evolving dynamics. The emphasis on community solidarity, proactive management of technological disruptions, integration of automation and AI, and prioritization of financial health reflect an industry in active pursuit of adaptation and growth. As the HME sector progresses, the insights from Medtrade provide critical guidance for professionals aiming to refine their operations and deliver superior patient care amidst the challenges of a changing healthcare landscape.

To explore how Prochant can help simplify your reimbursement, contact us today. Together, we can achieve a more profitable, efficient, and patient-focused future.

Prochant is the only AI-driven reimbursement service provider in the home-based care industry. We deliver focused revenue cycle management (RCM) solutions to healthcare providers with 7 wholly-owned global delivery centers. Our expertise lies in providing end-to-end RCM for home-based care, infusion, and specialty pharmacies, consistently delivering exceptional results to some of the leading healthcare providers in the country. We harness specialized automation technology and deep industry knowledge to streamline the time-consuming and expensive reimbursement process. As a result, we help healthcare providers accelerate their collections, increase revenue, and reduce operational costs while managing risk. Prochant is HITRUST certified, the gold standard for HIPAA security. For more information, please visit